Accessibility Menu
Cambridge Cognition Plc logo

Cambridge Cognition Plc(LSE) COG

Current Price£0.33
Market Cap£17.54MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2013)-59%
5 Year-82%
1 Year+0%
1 Month-7%
Cambridge Cognition Plc last closing stock price
MetricPriceDate
Last closeGBX 32.502026-07-22
Cambridge Cognition Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.17%GBX 31.502026-07-15
1 month-7.14%GBX 35.002026-06-22
3 month-10.96%GBX 36.502026-04-23
Year to date+16.07%GBX 28.002025-12-31
1 year+0%GBX 32.502025-07-22
3 year-65.96%GBX 95.472023-07-21
5 year-81.99%GBX 180.442021-07-23
Since inception-59.36%GBX 0.802013-04-18

Cambridge Cognition Plc Financials at a Glance

Market Cap

£17.54MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£19.74M

Net Income (TTM)

-£3.46M

EPS (TTM)

-£0.04

P/E Ratio

-8.42

Dividend

£0.00

Beta (Volatility)

0.09 (Low)

Price

£0.33

Volume

4,484

Open

£0.33

Previous Close

£0.33

Daily Range

£0.32 - £0.33

52-Week Range

£0.24 - £0.45

Estimated Earnings Date

Sep 29, 2026

COG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cambridge Cognition Plc

Cambridge Cognition Holdings Plc is a neuroscience technology company specializing in cognitive testing solutions for clinical settings. The firm operates globally, providing innovative products to clients in the United States, United Kingdom, and European Union.

Products and Services
  • CANTAB Recruit: Online platform for participant onboarding in clinical trials
  • CANTAB Connect: Digital cognitive assessment tools for various medical fields
  • Cognition Kit: Digital health platform utilizing wearables and apps for data collection
Growth Outlook
  • Recent quarterly revenue reached £5.1 million, indicating strong market demand
  • Gross profit margin improved to 71.15% in Q4 2025, showcasing operational efficiency
  • Expansion into high-need therapeutic areas like Alzheimer's disease supports future growth
Financial Highlights
  • Trailing twelve months (TTM) revenue of £20.5 million reflects consistent performance
  • Operating income improved to £536,000 in Q4 2025, signaling operational progress
  • Cash and cash equivalents increased to £1.1 million, enhancing liquidity position
Cambridge Cognition Holdings Plc is positioned in the healthcare information services sector, focusing on advanced cognitive assessment technologies. The company's diverse product portfolio addresses critical needs in clinical trials and cognitive research, particularly in areas with significant unmet medical needs. The recent financial performance indicates a positive trajectory, with increasing revenues and improved gross profit margins. The strategic focus on high-demand therapeutic areas, such as Alzheimer's disease, further enhances the company's growth potential. With a solid foundation and innovative offerings, Cambridge Cognition Holdings Plc presents an intriguing opportunity for investors interested in the healthcare technology space.
AI Generated • Jun 27, 2026

Industry

Health Care Technology

CEO

Robert Roland Baker

Headquarters

Cambridge, CAM CB25 9TU, GB

COG Financials

Key Financial Metrics (TTM)

Gross Margin

74.53%

Operating Margin

-16.50%

Net Income Margin

-17.82%

Return on Equity

-62.89%

Return on Capital

-40.11%

Return on Assets

-14.85%

Earnings Yield

-11.88%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£17.54MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

53.96M

Volume

4.48K

Avg. Volume

31.12K

Financials (TTM)

Gross Profit

£15.39M

Operating Income

-£2.72M

EBITDA

-£1.42M

Operating Cash Flow

-£3.11M

Capital Expenditure

-£33.00K

Free Cash Flow

-£3.14M

Cash & ST Invst.

£1.13M

Total Debt

£873.00K

Cambridge Cognition Plc Performance Analysis

Cambridge Cognition Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31GBP 12,613,00025.0%
20232023-12-31GBP 13,515,0007.2%
20242024-12-31GBP 10,342,000-23.5%
20252025-12-31GBP 9,400,000-9.1%
Cambridge Cognition Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-25.1%
Q42024-12-31-15.4%
Q22025-06-30-8.9%
Q42025-12-3117.8%
Cambridge Cognition Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31GBP -0.01N/A
20232023-12-31GBP -0.10674.0%
20242024-12-31GBP -0.05-54.4%
20252025-12-31GBP -0.04-16.5%
Cambridge Cognition Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-456.1%
Q42024-12-3149.8%
Q22025-06-30-50.9%
Q42025-12-3140.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

£5.09M

-32.0%

Gross Profit

£3.62M

-40.1%

Gross Margin

71.15%

N/A

Market Cap

£17.54MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£237.00K

N/A

Employees

74

N/A

Net Income

-£668.00K

-239.1%

EBITDA

-£345.00K

-135.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

£1.13M

-65.0%

Total Debt

£873.00K

-65.9%

Accounts Receivable

£2.09M

+35.3%

Inventory

£91.00K

-51.3%

Long Term Debt

£0.00

-100.0%

Short Term Debt

£873.00K

+49.5%

Return on Assets

-14.85%

N/A

Return on Invested Capital

-51.80%

N/A

Free Cash Flow

£203.00K

+112.9%

Operating Cash Flow

£225.00K

+114.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IHC.LInspiration Healthcare Group plc
£0.19+2.16%
ABDX.LAbingdon Health Plc
£0.10-2.56%
FAB.LFusion Antibodies plc
£0.10-6.05%
PXS.LProvexis plc
£0.01-4.17%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$10.28-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.96-0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.94+0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$70.28-0.02%

Questions About COG

What is the current price of Cambridge Cognition Plc?

Cambridge Cognition Plc is trading at £0.33 per share.

What is the 52-week range for Cambridge Cognition Plc?

Over the past 52 weeks, Cambridge Cognition Plc has traded between £0.24 and £0.45.

How much debt does Cambridge Cognition Plc have?

As of the most recent reporting period, Cambridge Cognition Plc reported total debt of £873.00K.

How much cash does Cambridge Cognition Plc have on hand?

Cambridge Cognition Plc reported £1.13M in cash and cash equivalents in its most recent financial results.

What is Cambridge Cognition Plc’s dividend yield?

Cambridge Cognition Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.